Search Results

Skyrizi Overtakes Humira in U.S. Sales Numbers.

• Authors : Jeremias, Skylar

Subjects: THERAPEUTIC use of monoclonal antibodies; ANKYLOSING spondylitis; PSORIASISUNITED States

• Source: Formulary Watch. 11/8/2024, p1-1. 1p. 2 Color Photographs.

Record details

PM2.5 Exposure of Mice during Spermatogenesis: A Role of Inhibitor jB Kinase 2 in Pro-Opiomelanocortin Neurons.

• Authors : Lianglin Qiu; Minjie Chen; Xiaoke Wang

Subjects: PITUITARY gland physiology; PARTICULATE matter; BIOLOGICAL models

• Source: Environmental Health Perspectives. Sep2021, Vol. 129 Issue 9, p1-097006-11. 11p. 4 Color Photographs, 1 Diagram, 2 Charts.

Record details

Atopic Dermatitis Treatment: Past, Present and Future.

Subjects: ATOPIC dermatitis; CUTANEOUS therapeutics; ANTI-inflammatory agents

• Source: Formulary Watch. 8/5/2024, p1-1. 1p.

Record details

FDA Approves Oral JAK Inhibitor for Alopecia.

Subjects: ALOPECIA areata; HAIR follicles; ORAL drug administration

• Source: Formulary Watch. 7/26/2024, p1-1. 1p.

Record details

AbbVie Submits Applications for Rinvoq for Giant Cell Arteritis.

Subjects: ANKYLOSING spondylitis; PSORIATIC arthritis; CROHN'S disease

• Source: Formulary Watch. 7/12/2024, p1-1. 1p.

Record details

The Right Chemistry.

• Authors : HERPER, MATTHEW (AUTHOR); KAM, KEN (AUTHOR)

Subjects: INCYTE Corp.; JANUS kinases; MYELOFIBROSIS

• Source: Forbes. 10/24/2017, Vol. 200 Issue 4, p35-38. 3p. 1 Color Photograph, 1 Chart.

Record details

FDA Approves GSK's Myelofibrosis Drug.

Subjects: THERAPEUTIC use of antineoplastic agents; DRUG approval; MYELOFIBROSIS

• Source: Formulary Watch. 9/18/2023, p1-2. 2p.

Record details

Best Read FDA Approval Stories in 2023.

Subjects: DRUG approval; BALDNESS; ANTIPARASITIC agents

• Source: Formulary Watch. 12/23/2023, p1-1. 1p.

Record details

FDA Approves Pfizer's Alopecia Drug.

Subjects: DRUG approval; ALOPECIA areata; DRUG efficacy

• Source: Formulary Watch. 6/26/2023, p1-1. 1p.

Record details

FDA OKs First Oral Drug for Crohn's Disease.

• Authors : Weiser, Patricia

Subjects: DRUG approval; CROHN'S disease; ORAL drug administration

• Source: Formulary Watch. 5/19/2023, p1-1. 1p.

Record details